{
    "name": "sotrovimab",
    "comment": "Investigational",
    "other_names": [
        "VIR-7831",
        "GSK4182136",
        "COVID-19 monoclonal antibody (VIR",
        "GSK)"
    ],
    "classes": [
        "COVID-19",
        "Monoclonal Antibodies"
    ],
    "source": "https://reference.medscape.com/drug/sotrovimab-4000220",
    "pregnancy": {
        "common": [
            "Insufficient data to evaluate drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes",
            "Use during pregnancy only if the potential benefit outweighs the potential risk for the mother and fetus",
            "No dosage adjustment recommended by the manufacturer",
            "Nonclinical reproductive toxicity studies have not been conducted",
            "Sotrovimab is an Fc-enhanced human IgG and may have the potential for placental transfer from mother to developing fetus"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Data are unknown regarding presence in human or animal milk, effects on breastfed infants, or effects on milk production",
            "Maternal IgG is known to be present in human milk",
            "No dosage adjustment recommended by the manufacturer"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "EUA requirement",
            "percent": null
        },
        {
            "name": "Completion of FDA MedWatch Form to report all medication errors and serious adverse events is mandatory",
            "percent": null
        }
    ]
}